v3.8.0.1
Note G - Stockholders' Equity
12 Months Ended
Dec. 31, 2016
Notes  
Note G - Stockholders' Equity

Note G – Stockholders' Equity

 

Common Stock

 

We are authorized to issue 2,000,000,000 shares of our $0.0001 par value common stock, of which 159,883,328 were issued and outstanding at December 31, 2016.

 

On June 14, 2016, we issued 2,000 shares of stock to our former officers and directors in exchange for modification  of some terms of their debt agreements with the Company (Note C).

 

During August and September 2016, we sold 4,000,000 shares of our common stock, with warrants to purchase an additional 6,000,000 shares of our common stock, to a group of private investors for $100,000.  The warrants are exercisable at prices between $0.05 and $0.20 per share at any time between June 30, 2017 and June 30, 2019.  Each series of warrants was valued using the Black-Scholes Options Pricing Model resulting in total warrant value of $85,833. The remaining proceeds of $14,167 were allocated to the common stock.  Black-Scholes data inputs used to value the warrants are as follows:

 

 

 

 

Warrants

 

Stock Price

 

Exercise Price

 

Expected Life (Yrs)

 

Risk-Free Rate

 

Warrant Value

Number of Warrants

 

Extended Value

Series A

$.025

$.05

.75

.54%

$.010625

2,000,000

$21,249

Series B

$.025

$.10

1.75

.69%

$.014909

2,000,000

$29,817

Series C

$.025

$.20

1.75

.85%

$.017384

2,000,000

$34,767

Total

 

 

 

 

 

 

$85,833

 

On October 27, 2016, we acquired 100% of the issued and outstanding shares of Advantego Technologies, Inc. ("Advantego") common stock in exchange for 127,915,000 shares of our common stock.

 

On December 30, 2016, $115,000 of the Gulf Coast Capital, LLC note payable (Note F) was converted into 4,600,000 shares of our common stock.

 

Preferred stock

 

Our Articles of Incorporation provide that we may issue up to 10,000,000 shares of various series of preferred stock.  Subject to the requirements of the Colorado Business Corporation Act, the Board of Directors may issue the preferred stock in series with rights and preferences as the Board of Directors may determine appropriate, without shareholder approval.  As of December 31, 2016, 4,500,000 shares of our Series B Preferred Stock had been authorized for issuance, and 240,000 were issued and outstanding.  These 240,000 Series B shares are convertible into 120,000 common shares.